Invention Grant
- Patent Title: Combination immunotherapy for the treatment of cancer
-
Application No.: US15971983Application Date: 2018-05-04
-
Publication No.: US10167337B2Publication Date: 2019-01-01
- Inventor: James Allison , Padmanee Sharma , Sergio A. Quezada , Tihui Fu
- Applicant: Board of Regents, The University of Texas System , Memorial Sloan-Kettering Cancer Center
- Applicant Address: US NY New York US TX Austin
- Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER,BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER,BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US NY New York US TX Austin
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K38/17 ; A61K39/00
Abstract:
Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
Public/Granted literature
- US20180251555A1 Combination Immunotherapy For The Treatment of Cancer Public/Granted day:2018-09-06
Information query
